PAPER Arafi P, Devkota S, Williams E, Maesako M, Wolfe MS
SEARCH RESULTS
1782 RESULTS
PAPER Stefani A, Antelmi E, Arnaldi D, Arnulf I, During E, Högl B, Hu MM, Iranzo A, Luke R, Peever J, Postuma RB, Videnovic A, Gan-Or Z
From mechanisms to future therapy: a synopsis of isolated REM sleep behavior disorder as early synuclein-related disease.
Mol Neurodegener. 2025 Feb 11;20(1):19. PubMed.PAPER Furusawa-Nishii E, Solongo B, Rai K, Yoshikawa S, Chiba A, Okuzumi A, Ueno SI, Hoshino Y, Imamichi-Tatano Y, Kimura H, Hatano T, Hattori N, Miyake S
α-Synuclein orchestrates Th17 responses as antigen and adjuvant in Parkinson's disease.
J Neuroinflammation. 2025 Feb 11;22(1):38. PubMed.PAPER Otero-Jimenez M, Wojewska MJ, Binding LP, Jogaudaite S, Gray-Rodriguez S, Young AL, Gentleman S, Alegre-Abarrategui J
Neuropathological stages of neuronal, astrocytic and oligodendrocytic alpha-synuclein pathology in Parkinson's disease.
Acta Neuropathol Commun. 2025 Feb 11;13(1):25. PubMed.PAPER Simitsi AM, Sfikas E, Koros C, Papagiannakis N, Beratis I, Papadimitriou D, Antonellou R, Fragiadaki S, Kontaxopoulou D, Picillo M, Pachi I, Alefanti I, Stamelou M, Barone P, Stefanis L
Motor and nonmotor features of p.A53T alpha-synuclein PD vs idiopathic PD: longitudinal data from the PPMI study.
J Neurol. 2025 Feb 12;272(3):203. PubMed.PAPER Outeiro TF, Höglinger G, Lang AE, Vieira TC
Protein misfolding: understanding biology to classify and treat synucleinopathies.
J Neural Transm (Vienna). 2025 Feb 11; Epub 2025 Feb 11 PubMed.PAPER Ren J, Xie D, Wang L, Wu Z, Lin S, Jin Q, Luo Y, Zhu B, Huang H, Wang J, Zhang S, Liu Z, Chen G, Luo M, Yang D
Glymphatic system dysfunction as a biomarker of disease progression in Parkinson's disease: neuroimaging evidence from longitudinal cohort studies.
J Neurol. 2025 Feb 11;272(3):196. PubMed.PAPER Zheng C, Zhao W, Yang Z, Guo S, Alzheimer’s Disease Neuroimaging Initiative
Dysfunction in the hierarchy of morphometric similarity network in Alzheimer's disease and its correlation with cognitive performance and gene expression profiles.
Psychol Med. 2025 Feb 12;55:e42. PubMed.PAPER Mengr A, Šmotková Z, Pačesová A, Železná B, Kuneš J, Maletínská L
Reduction of Neuroinflammation as a Common Mechanism of Action of Anorexigenic and Orexigenic Peptide Analogues in the Triple Transgenic Mouse Model of Alzheimer´s Disease.
J Neuroimmune Pharmacol. 2025 Feb 11;20(1):18. PubMed.PAPER Pasquini J, Sigurdsson HP, Firbank M, Best L, Foster V, Galley D, Maxwell R, Silani V, Ceravolo R, Petrides G, Brooks DJ, Pavese N
Locus coeruleus neuromelanin, cognitive dysfunction, and brain metabolism in multiple system atrophy.
J Neurol. 2025 Feb 11;272(3):195. PubMed.PAPER Qiu Y, Zhao Y, He G, Yang D
Porphyromonas gingivalis and Its Outer Membrane Vesicles Induce Neuroinflammation in Mice Through Distinct Mechanisms.
Immun Inflamm Dis. 2025 Feb;13(2):e70135. PubMed.PAPER Feng X, Zhao S
Untargeted urine metabolomics reveals dynamic metabolic differences and key biomarkers across different stages of Alzheimer's disease.
Front Aging Neurosci. 2025;17:1530046. Epub 2025 Jan 27 PubMed.PAPER Kovalenko EA, Makhnovich EV, Pervunina AV, Gileva EA, Bogolepova AN
[Non-invasive biomarkers for early diagnosis of Alzheimer's disease in bodily fluids].
Zh Nevrol Psikhiatr Im S S Korsakova. 2025;125(1):8-16. PubMed.PAPER Choquet D, Opazo P, Zhang H
AMPA receptor diffusional trapping machinery as an early therapeutic target in neurodegenerative and neuropsychiatric disorders.
Transl Neurodegener. 2025 Feb 11;14(1):8. PubMed.PAPER Pérez-Millan A, Lal-Trehan Estrada UM, Falgàs N, Guillén N, Borrego-Écija S, Juncà-Parella J, Bosch B, Tort-Merino A, Sarto J, Augé JM, Antonell A, Bargalló N, Ruiz-García R, Naranjo L, Balasa M, Lladó A, Sala-Llonch R, Sánchez-Valle R
The Cortical Asymmetry Index for subtyping dementia patients.
Eur Radiol. 2025 Feb 11; Epub 2025 Feb 11 PubMed.Current Filters
- Date Range : Feb 2025 to Mar 2025 x